- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05649657
Effect of Lifestyle Intervention in Patients With Chronic Kidney Disease on Fitness and Immune Function
December 12, 2022 updated by: Chang Gung Memorial Hospital
To assess the efficacy of a 6-month lifestyle intervention in patients with CKD, we plan to conduct a self-controlled clinical trial.
120 participants with CKD stage 3-5 will be enrolled.
In addition, 20 participants with CKD stages 1 and 2 respectively, and 20 healthy subjects will be recruited; they will receive physical fitness and immune function assessment once; no intervention will be given.
The participants with 3-5 CKD will go through three phases: 3-month control, 6-month intervention, and 3-month maintenance.
No intervention will be performed in the control and maintenance phases.
The lifestyle intervention will comprise care from a multidisciplinary team, including a nephrologist, nurse practitioner, physiatrist, and dietitian.
The exercise training component will offer two options for the participants to choose from.
First, a two-week individualized and supervised center-based exercise intervention followed by 6 months of a home-based program with refresher visits once per month.
The participant will be requested to wear a heart rate recorder during home exercise.
Second, persistent in-hospital training 2~3 times weekly for 6 months.
Cyclic aerobic and resistance training will be performed.
Assessment will be performed every three months and 5 times in total, including cardiopulmonary exercise testing, isokinetic quadriceps strength testing, hand grip strength, body composition analysis, Chinese Kidney Disease and Quality of Life questionnaire, self-recorded physical activity, and Mini Nutritional Assessment.
The aim of this study is to assess the efficacy of a lifestyle intervention in patients with CKD on physical fitness, quality of life, and immunity.
It is hypothesized that the lifestyle intervention will elicit a significant benefit in the aforementioned parameters and will last until the maintenance phase.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The prevalence of chronic kidney disease (CKD) in stages 3~5 is as high as 11.6% in Taiwan.
Cardiovascular diseases and infection are the major causes of morbidity.
Though evidence is clear that exercise training in this population is beneficial to fitness、quality of life、morbidity, it is seriously underused.
Poor physical fitness is known to associate with high-leveled systemic inflammation and immune dysregulation but the detailed relationship remains unclear in the CKD population.
Moreover, though exercise improves low physical fitness, available research concerning its effect on the pro-/anti-inflammatory immune response is scarce.
Does supervised lifestyle intervention has the potential to improve physical fitness, quality of life and immunity in patients with chronic kidney disease (CKD)?
To assess the efficacy of a 6-month lifestyle intervention in patients with CKD, we plan to conduct a self-controlled clinical trial.
120 participants with CKD stage 3-5 will be enrolled.
In addition, 20 participants with CKD stages 1 and 2 respectively, and 20 healthy subjects will be recruited; they will receive physical fitness and immune function assessment once; no intervention will be given.
The participants with 3-5 CKD will go through three phases: 3-month control, 6-month intervention, and 3-month maintenance.
No intervention will be performed in the control and maintenance phases.
The lifestyle intervention will comprise care from a multidisciplinary team, including a nephrologist, nurse practitioner, physiatrist, and dietitian.
The exercise training component will offer two options for the participants to choose from.
First, a two-week individualized and supervised center-based exercise intervention followed by 6 months of a home-based program with refresher visits once per month.
The participant will be requested to wear a heart rate recorder during home exercise.
Second, persistent in-hospital training 2~3 times weekly for 6 months.
Cyclic aerobic and resistance training will be performed.
Assessment will be performed every three months and 5 times in total, including cardiopulmonary exercise testing, isokinetic quadriceps strength testing, hand grip strength, body composition analysis, Chinese Kidney Disease and Quality of Life questionnaire, self-recorded physical activity, and Mini Nutritional Assessment.
The aim of this study is to assess the efficacy of a lifestyle intervention in patients with CKD on physical fitness, quality of life, and immunity.
It is hypothesized that the lifestyle intervention will elicit a significant benefit in the aforementioned parameters and will last until the maintenance phase.
The goal for each year is as follows.
The FIRST year: To explore the relationship between physical fitness and pro-/anti-inflammatory immune response in different stages of CKD patients; the SECOND year: to assess the effect of lifestyle intervention on physical fitness, QOL, sedentary time, and nutrition status; the THIRD year: To evaluate the effects of lifestyle intervention on immunity.
Study Type
Interventional
Enrollment (Anticipated)
160
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Shu-Chun Huang, MD, PhD
- Phone Number: 5156 +8863281200
- Email: mr7171@cgmh.org.tw
Study Locations
-
-
-
Taoyuan, Taiwan, 333
- Recruiting
- Chang Gung memorial hospital
-
Contact:
- Shu-Chun Huang, MD, PhD
- Phone Number: 5156 +8863281200
- Email: mr7171@cgmh.org.tw
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients with CKD in stages 3-5
- patients who are on HD for longer than 6 months
- under the permission of their nephrologist
- adequately dialyzed (most recent Kt/V > 1.2) and stable during dialysis in the past 3 months
Exclusion Criteria:
- occurrence of hyperkalemia in the past 3 months
- comorbid medical, physical, and mental conditions that contraindicate exercise
- unstable cardiac conditions (eg, unstable angina, heart failure or symptomatic severe aortic stenosis, etc.)
- disabling orthopedic and neuromuscular diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CKD patients with exercise training intervention
The participants with 3-5 CKD will go through three phases: 3-month control, 6-month intervention, and 3-month maintenance.
No intervention will be performed in the control and maintenance phases
|
Two options for the participants to choose from.
First, a home-based program.
The participant will be requested to wear a heart rate recorder during home exercise.
Second, a hospital-based program.
The participants visit the rehabilitation center twice weekly to receive supervised exercise therapy.
The exercise prescription comprises aerobic and resistance training.
The intensity is set initially at ventilatory anaerobic threshold and gradually titrated up to respiratory compensatory point based on the breath-by-breath cardiopulmonary exercise testing.
The duration is 25~35 minutes per session plus a 5-minute warm-up and 5-min cool-down.
The frequency is 2~3 sessions per week and about 70 sessions in total.
|
No Intervention: CKD stage 1 and 2
no inervention
|
|
No Intervention: CKD stage 1 and 2 respectively, and 20 healthy subjects
no inervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Exercise capacity of all participants by Cardiopulmonary Exercise Test (CPET)
Time Frame: three years
|
Cardiopulmonary Exercise Test cardiopulmonary exercise test.
|
three years
|
To examine the levels of inflammatory chemokines in the circulation of participants by Luminex assay
Time Frame: three years
|
Luminex assay
|
three years
|
To detect the levels of anti-inflammatory microRNAs in the circulation of participants by qPCR
Time Frame: three years
|
qPCR
|
three years
|
To study various populations of immune cells in the circulation of patients
Time Frame: three years
|
flow cytometry
|
three years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
To evaluate the association between fitness and immune responses by the questionnaire of Hong Kong Chinese Kidney Disease and Quality of Life
Time Frame: three years
|
The minimum and maximum values of the Hong Kong Chinese Kidney Disease and Quality of Life questionnaire are 0 and 100, separately.
The higher scores mean a better outcome.
|
three years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Shu-Chun Huang, MD, PhD, Chang Gung memorial hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 20, 2022
Primary Completion (Anticipated)
September 18, 2024
Study Completion (Anticipated)
September 18, 2025
Study Registration Dates
First Submitted
November 7, 2022
First Submitted That Met QC Criteria
December 12, 2022
First Posted (Actual)
December 14, 2022
Study Record Updates
Last Update Posted (Actual)
December 14, 2022
Last Update Submitted That Met QC Criteria
December 12, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202201244B0A3
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Kidney Diseases
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
American Academy of Family PhysiciansUniversity of Colorado, Denver; National Institute of Diabetes and Digestive... and other collaboratorsCompletedChronic Kidney Disease | Chronic Renal Insufficiency | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney Insufficiency, ChronicUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
Centre Hospitalier le MansLe Mans UniversiteWithdrawnFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage3 | Chronic Kidney Failure | Chronic Kidney Disease, Stage 4 (Severe)
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
-
Centre Hospitalier le MansLe Mans UniversiteRecruitingFatigue | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease Stage 3BFrance
-
University of WashingtonJohns Hopkins University; National Institute of Diabetes and Digestive and... and other collaboratorsRecruitingChronic Kidney Diseases | Acute Renal Failure | Acute Renal Injury | Acute Kidney Failure | Chronic Renal Insufficiency | Kidney Failure, Acute | Renal Insufficiency, Acute | Acute Renal Insufficiency | Acute Kidney Insufficiency | Renal Failure, Acute | Chronic Kidney Insufficiency | Chronic Renal Diseases | Kidney... and other conditionsUnited States
-
University of the State of Santa CatarinaUnknownKidney Diseases | Chronic Kidney Diseases | Hemodialysis | Chronic Renal Insufficiency | Renal Dialysis | Chronic Kidney Insufficiency | Chronic Renal DiseasesBrazil
-
Texas A&M UniversityWithdrawnChronic Kidney FailureUnited States
-
Lund UniversityBaxter Healthcare Corporation; Universidad de CórdobaCompletedEnd Stage Kidney Disease | Chronic Kidney Disease Requiring Chronic DialysisArgentina
Clinical Trials on Cyclic aerobic and resistance training
-
University of BarcelonaCompleted
-
Onassis Cardiac Surgery CentreInstitute of Cardiology, Warsaw, Poland; Asklepieion Voulas General HospitalCompletedHeart FailureGreece, Poland
-
Biomedical Research Institute of New MexicoBaylor College of Medicine; National Institute on Aging (NIA)Completed
-
Riphah International UniversityRecruitingCardiovascular DiseasesPakistan
-
University of Illinois at ChicagoNational Heart, Lung, and Blood Institute (NHLBI)RecruitingCardiovascular Diseases | Vascular Diseases | HypertensionUnited States
-
National Cardiovascular Center Harapan Kita Hospital...Completed
-
Nanjing University of Traditional Chinese MedicineGuangxi Medical University; Southeast University, ChinaUnknown
-
University of AarhusOxford Brookes UniversityRecruiting
-
University of Alabama at BirminghamNational Institute on Aging (NIA)Completed
-
Universita di VeronaCompleted